SCHEMBL21596796

SCHEMBL21596796

Nc1noc2cc(-c3ncccn3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.42
F9 P00740 1/20 0.40
PIK3CD O00329 1/20 0.40
PIP5K1C O60331 1/20 0.40
PI4KA P42356 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
GSK3B P49841 1/20 0.40
KIT P10721 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37
F11 P03951 3/20 0.37
ADRB2 P07550 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
IDO1 P14902 2/20 0.35
LTB4R Q15722 1/20 0.35
EPHX2 P34913 1/20 0.34
CLK4 Q9HAZ1 2/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596874 0.83 PIK3CD (0.43) MAPK14F9PIK3CDPI4KAPIK3CG
SCHEMBL29652589 0.83 PIK3CD (0.43) MAPK14F9PIK3CDPI4KAPIK3CG
SCHEMBL14072365 0.78 MAP4K4 (0.52) MAPK14F9F11DYRK1A
SCHEMBL15638775 0.77 FEN1 (0.49) MAPK14F9GSK3BKITKDR
SCHEMBL21596858 0.76 BRD4 (0.41) MAPK14F9GSK3BKDRF11
SCHEMBL13376464 0.74 MAP4K4 (0.58) MAPK14F9GSK3BKITKDR
SCHEMBL21596920 0.73 PIK3CD (0.43) PIK3CDPIP5K1CPI4KAPIK3CGPI4KB
SCHEMBL7072970 0.73 MAP4K4 (0.46) MAPK14F9KITKDRFLT3
SCHEMBL8276224 0.73 MAP4K4 (0.42) MAPK14F9F11
SCHEMBL12441328 0.73 F11 (0.46) MAPK14F9GSK3BF11ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 MAPK14 661/4885F9 205/4885PIK3CD 1600/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 MAPK14 662/4885F9 205/4885PIK3CD 1606/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B MAPK14 3034/4885F9 77/4885PIK3CD 1209/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 MAPK14 662/4885F9 205/4885PIK3CD 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.